Alliance Announces FDA Approval of Atezolizumab Based on Results from the Phase III ATOMIC Trial for Patients with Stage III dMMR Colon Cancer
Editor's Note: This article, reprinted in full, was originally written and shared with us by Alliance. To see the article in its original format, please click here. The Alliance for…
Continue Reading
Alliance Announces FDA Approval of Atezolizumab Based on Results from the Phase III ATOMIC Trial for Patients with Stage III dMMR Colon Cancer
